Howorth appoints technical director

Michael Mellor will develop aseptic isolator range

Michael Mellor has rejoined Howorth as technical director, after spending six months at Telstar Group as technical manager.

Mellor has a particular interest in developing a range of aseptic isolators. He will join David Jackson, director and general manager of the pharmaceutical division.

The two men will work closely together to increase global business by taking Howorth’s pharmaceutical products to new markets, as well as consolidating the company’s success with its existing client base.

Howorth said 2010 was a successful year for the pharmaceutical division, which completed several projects for companies including GlaxoSmithKline, Eisai, sanofi-aventis, Teva and Almirall.

In 2011, the firm will appoint agents in the Far East as part of its global expansion.

You may also like

Containment

UK-based Howorth Air Technology expands into the US

The clean air expert has announced an expansion in North Carolina that will enable the company to serve a wider customer base across North America for its containment solutions and services
Design & Build

MIDDAS supplies freestanding cleanroom for Howorth

Howorth Air Technology required a freestanding cleanroom for their client (MSD), for sampling pharmaceutical compounds within their proprietary isolators and sampling booths
Design & Build

Howorth installs screenless UCV canopy at UK hospital

The company has completed work at a brand new operating theatre complex at a Leighton hospital 
Design & Build

Howorth joins team building £20m pharma manufacturing centre in South Devon

Takes responsibility for the provision of graded cleanrooms, sterile areas, a dispensary and specialist HVAC
Design & Build

London hospital project nearing completion

Project started as a single modular theatre, but requirements changed and the scheme grew considerably
Design & Build

Howorth Air Technology collaborates with G-CON Manufacturing

Becomes preferred service provider of G-CON mobile cleanroom PODs
You need to be a subscriber to read this article.
Click here to find out more.
Media

The UK banks on research and science

UK industry is currently beset by high business costs, overly cautious lending and government austerity measures. But some support for r&d has been forthcoming through recent UK Government funding and tax credits, while regional grants are encouraging investment in some areas. The pharmaceutical industry accounts for 60% of r&d spending in the UK, but other sectors such as healthcare, automotive and the space industry, are offering opportunities for cleanroom suppliers.
Subscribe now